Ariceum Therapeutics logo

Ariceum Therapeutics jobs and careers

Berlin, Germany

About Ariceum Therapeutics

Ariceum Therapeutics is a privately held radiopharmaceutical firm in the clinical stage that specializes in the detection and targeted treatment of aggressive malignancies, such as neuroendocrine and other hard-to-treat cancers.177Lu-satoreotide tetraxetan (Satoreotide), the company's primary targeted systemic radiopharmaceutical therapy, isan antagonist of the somatostatin type 2 receptor (SSTR2), which is overexpressed in many neuroendocrine tumors. For the simultaneous diagnosis and targeted radionuclide treatment of neuroendocrine malignancies, some aggressive tumors, and childhood cancer, which currently offers few treatment choices and a poor prognosis, we are developing satoreotide as a "theranostic" pair.

Founded
2021
Employees
11 to 50
Total funding
$47.8M
Headquarters
Berlin

Leadership

The top of Ariceum Therapeutics's org chart, with how many people report into each leader.

MRPhoto of Manfred Ruediger

Manfred Ruediger

CEO of Ariceum Therapeutics GmbH

11 reports

SM

Susanna Mesa

Chief Operating Officer

5 reports

PDPhoto of Prachi Desai

Prachi Desai

Scientist

PJ

Pierre Jordaan

Director Pharmacovigilance

AMPhoto of Aaron Block, MBA

Aaron Block, MBA

Senior Director / Head of Strategy and Business Development

MH

Marion H.

CMC Manager

CGPhoto of Carina Graß

Carina Graß

Scientist

Jobs at Ariceum Therapeutics

No open positions right now. Explore more companies on TheJobsMap.